000 02368 a2200637 4500
005 20250517001617.0
264 0 _c20150918
008 201509s 0 0 eng d
022 _a1573-0646
024 7 _a10.1007/s10637-014-0176-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFalchook, Gerald S
245 0 0 _aDual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors.
_h[electronic resource]
260 _bInvestigational new drugs
_cFeb 2015
300 _a215-24 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAngiogenesis Inhibitors
_xadministration & dosage
650 0 4 _aAntibodies, Monoclonal, Humanized
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aBevacizumab
650 0 4 _aClass I Phosphatidylinositol 3-Kinases
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMutation
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aNiacinamide
_xadministration & dosage
650 0 4 _aPTEN Phosphohydrolase
_xgenetics
650 0 4 _aPhenylurea Compounds
_xadministration & dosage
650 0 4 _aPhosphatidylinositol 3-Kinases
_xgenetics
650 0 4 _aPolymorphism, Single Nucleotide
650 0 4 _aProto-Oncogene Proteins
_xgenetics
650 0 4 _aReceptors, Vascular Endothelial Growth Factor
_xantagonists & inhibitors
650 0 4 _aSorafenib
650 0 4 _aTumor Suppressor Protein p53
_xgenetics
650 0 4 _aVascular Endothelial Growth Factor A
_xantagonists & inhibitors
700 1 _aWheler, Jennifer J
700 1 _aNaing, Aung
700 1 _aPiha-Paul, Sarina A
700 1 _aFu, Siqing
700 1 _aTsimberidou, Apostolia M
700 1 _aHong, David S
700 1 _aJanku, Filip
700 1 _aZinner, Ralph
700 1 _aJiang, Yunfang
700 1 _aHuang, Mei
700 1 _aLin, Quan
700 1 _aParkhurst, Kristin
700 1 _aKurzrock, Razelle
773 0 _tInvestigational new drugs
_gvol. 33
_gno. 1
_gp. 215-24
856 4 0 _uhttps://doi.org/10.1007/s10637-014-0176-4
_zAvailable from publisher's website
999 _c24322328
_d24322328